Using Registers to Study Effectiveness and Safety of Drugs

Using Registers to Study Effectiveness and Safety of Drugs

Show other versions (1)

The article discusses the main aspects of registers use to evaluate the effectiveness and safety of drugs. It is noted that the results of the randomized clinical trials are currently constitute the highest level of evidence in medicine, but they have several limitations. Besides, in manycases evide...

Full description

Bibliographic Details
Main Authors:	L. Yu. Drozdova, N. P. Kutishenko, M. L. Ginzburg
Format:	Article
Language:	Russian
Published:	ABV-press 2014-07-01
Series:	Klinicist
Subjects:	register randomized clinical trials observational studies effectiveness of drugs
Online Access:	https://klinitsist.abvpress.ru/Klin/article/view/47

Similar Items

Using Registers to Study Effectiveness and Safety of Drugs
by: L. Yu. Drozdova, et al.
Published: (2014-07-01)

New approaches in drug safety assessment based on information provided by doctors and patients in the register “PROFILE”
by: N. A. Dmitrieva, et al.
Published: (2020-01-01)

Randomised Clinical Trials and Observational Studies: the Ratio in the Hierarchy of Evidence of the Efficacy of Drugs
by: S. Yu. Martsevich, et al.
Published: (2016-11-01)

Efficacy, Safety and Long-term Outcomes of Nicorandil Use in Patients with Stable Ischemic Heart Disease According to the Results of Randomized and Observational Studies
by: Yu. V. Lukina, et al.
Published: (2019-11-01)

THE CAPABILITIES OF A REGISTER AS A QUALITY CONTROL OF THE PHARMACOTHERAPY IN OUTPATIENTS AT HIGH RISK OF CARDIOVASCULAR COMPLICATIONS (THE "LIS-1" REGISTER)
by: M. L. Ginzburg, et al.
Published: (2015-09-01)

EVALUATION OF THE CONFORMITY OF CARDIOVASCULAR THERAPY TO CURRENT CLINICAL GUIDELINES IN THE IMPROVEMENT OF OUTCOMES IN PATIENTS AFTER STROKE (ACCORDING TO THE LIS-2 REGISTER)
by: A. Yu. Suvorov, et al.
Published: (2015-09-01)

Clinical Trials Evaluating Drug Therapy: Types, Reliability of Results, Place in Modern Evidence-Based Medicine
by: S. Yu. Martsevich, et al.
Published: (2021-05-01)

Benefits and harms of the human papillomavirus (HPV) vaccines: comparison of trial data from clinical study reports with corresponding trial register entries and journal publications
by: Lars Jørgensen, et al.
Published: (2020-02-01)

Registers of psoriatic arthritis. Literature review
by: A. D. Koltakova
Published: (2019-05-01)

NEWS FROM THE ANNUAL CONGRESS OF EUROPEAN SOCIETY OF CARDIOLOGY (BARCELONA 2014): REALIZED AND UNREALIZED EXPECTATIONS
by: S. Y. Martsevich, et al.
Published: (2015-09-01)

Study-based registers of randomized controlled trials: Starting a systematic review with data extraction or meta-analysis
by: Farhad Shokraneh, et al.
Published: (2017-09-01)

ONCE AGAIN ABOUT THE HIERARCHY OF EVIDENCES IN MEDICINE OR WHETHER IT IS POSSIBLE TO CHOOSE THE MOST EFFECTIVE AND SAFE DRUG WITH THE HELP OF OBSERVATIONAL STUDIES
by: S. Y. Martsevich, et al.
Published: (2017-05-01)

News of the European Society of Cardiology Congress (London, 28 August - 2 September 2015): old drugs may be better than the new ones
by: S. Yu. Martsevich, et al.
Published: (2015-11-01)

DRUG SAFETY DATA COVERAGE IN MEDICAL LITERATURE
by: Yu. V. Muravyev, et al.
Published: (2015-09-01)

Efficacy and safety of escitalopram versus desvenlafaxine in the treatment of major depression: A preliminary 1-year prospective randomized open label comparative trial
by: Brij Mohan Gupta, et al.
Published: (2016-01-01)

News of the Annual Congress of the European Society of Cardiology in Rome: the Obvious and Proven - it's not the Same Thing
by: S. Yu. Martsevich, et al.
Published: (2016-11-01)

Comparative effectiveness research and its utility in In-clinic practice
by: Amit Dang, et al.
Published: (2016-01-01)

Effective monitoring of drug safety in the region
by: Shatalova O.V., et al.
Published: (2012-12-01)

Agreement between PRE2DUP register data modeling method and comprehensive drug use interview among older persons
by: Taipale H, et al.
Published: (2016-10-01)

ADVERSE EVENT OF DRUG THERAPY (THE FIRST RESULTS OF THE STUDY ACCORDING TO THE PROFILE OUTPATIENT REGISTER)
by: Yu. V. Lukina, et al.
Published: (2016-06-01)

National and transnational drug shortages: a quantitative descriptive study of public registers in Europe and the USA
by: Reko Ravela, et al.
Published: (2022-07-01)

Analysis of AYUSH studies registered in clinical trials registry of India from 2009 to 2020
by: M.S. Shree Devi, et al.
Published: (2021-04-01)

Using the Cochrane Central Register of Controlled Trials to identify clinical trial registration is insufficient: a cross-sectional study
by: Masahiro Banno, et al.
Published: (2020-07-01)

Effect of therapeutic versus prophylactic anticoagulation therapy on clinical outcomes in COVID-19 patients: a systematic review with an updated meta-analysis
by: Hong Duo, et al.
Published: (2022-08-01)

Registering Study Analysis Plans (SAPs) Before Dissecting Your Data—Updating and Standardizing Outcome Modeling
by: Maria Thor, et al.
Published: (2020-06-01)

LIS-3 REGISTER OF THE ACUTE CORONARY SYNDROME: WHAT HAS CHANGED IN A "PORTRAIT" OF A PATIENT AND SHORT-TERM OUTCOMES OF THE DISEASE COMPARED TO LIS-1 REGISTER
by: S. Yu. Martsevich, et al.
Published: (2017-03-01)

Cluster randomised trials of prescribing policy: an ethical approach to generating drug safety evidence? A discussion of the ethical application of a new research method
by: Amy Rogers, et al.
Published: (2020-06-01)

Swedish guidelines for registry-based randomized clinical trials
by: Karl Nyberg, et al.
Published: (2019-01-01)

Clinical trials in Irkutsk Scientific Center of Surgery and Traumatology: results and prospects
by: K. A. Apartsin, et al.
Published: (2016-07-01)

THE WAY OF ASSESSING THE ADHERENCE TO MODERN DRUG THERAPY CLINICAL GUIDELINES AIMED AT REDUCING THE RISK OF RECURRENT STROKE (ACCORDING TO THE LIS-2 REGISTER)
by: A. Yu. Suvorov, et al.
Published: (2015-09-01)

Systematic review of the registered clinical trials for coronavirus disease 2019 (COVID-19)
by: Rui-fang Zhu, et al.
Published: (2020-07-01)

TRUST Study: Participation in Randomized Controlled Trials and Subsequent Adherence to Visiting Medical Institutions and Taking Medications in Patients with Cardiovascular Diseases. Part II. Assessment of the Quality of Therapy
by: N. O. Vasyukova, et al.
Published: (2020-12-01)

THE ANALYSIS OF LONG-TERM OUTCOMES AND ADHERENT TO TREATMENT IN PATIENTS AFTER MYOCARDIAL INFARCTION: KHABAROVSK REGISTER DATA
by: I. M. Davidovich, et al.
Published: (2017-07-01)

Russian Register of Pregnancy and Epilepsy
by: D. V. Dmitrenko, et al.
Published: (2017-06-01)

Therapeutic drug monitoring (TDM) as intervention: A cross-sectional analysis of characteristics of 173 registered clinical trials
by: Shanshan Zhao, et al.
Published: (2022-12-01)

Safety of the Russian antiviral drug Kagocel
by: T G Borovskaya
Published: (2017-11-01)

Validation of Instruments for Assessing Drug Safety Management During the Conduction of Clinical Trials
by: Yaimarelis Saumell, et al.
Published: (2018-07-01)

THE LIS STUDY (LYUBERTSY STUDY ON MORTALITY RATE IN PATIENTS AFTER ACUTE MYOCARDIAL INFARCTION). EVALUATION OF DRUG THERAPY. PART 2. INFLUENCE OF PREVIOUS DRUG TREATMENT ON LONG-TERM LIFE PROGNOSIS
by: S. Yu. Martsevich, et al.
Published: (2015-12-01)

Clinical Trials Focusing on Drug Control and Prevention of Ventilator-Associated Pneumonia: A Comprehensive Analysis of Trials Registered on ClinicalTrials.gov
by: Lingmin Chen, et al.
Published: (2019-02-01)

Biomarkers navigate drug development: Pharmacology, effectiveness and safety
by: Daohong Chen
Published: (2024-02-01)